0 items USD 0.00Search
Your search for "Generic Drugs" gave back 31 results.
The Future of Generic Drugs and Strategies for Commercial Success Summary GBI Research鈥檚 latest report 鈥淭he Future of Generic Drugs and Strategies...
颁补迟补濒辞驳:听
CBR Pharma Insights
September 2016
Price: USD 2,995.00
Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the...
颁补迟补濒辞驳:听
CBR Pharma Insights
November 2016
Price: USD 2,995.00
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and...
颁补迟补濒辞驳:听
La Merie Publishing
May 2020
Price: USD 2,350.00
Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design Summary GBI...
CBR Pharma Insights
March 2017
Price: USD 2,995.00
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2019
Price: USD 2,995.00
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary GBI Research鈥檚 latest report 鈥淚nnovation Tracking Factbook...
颁补迟补濒辞驳:听
CBR Pharma Insights
December 2018
Price: USD 2,995.00
Healthcare Providers in the Netherlands - Market Summary, Competitive Analysis and Forecast to 2025 Summary Healthcare Providers in the Netherlands...
颁补迟补濒辞驳:听
MarketLine
March 2021
Price: USD 350.00
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players Summary GBI Research鈥檚 latest...
颁补迟补濒辞驳:听
CBR Pharma Insights
May 2018
Price: USD 2,995.00
Strategic Trends in Private Equity and Venture Capital Funding for Healthcare Summary GBI Research鈥檚 latest report, "Strategic Trends in Private...
颁补迟补濒辞驳:听
CBR Pharma Insights
November 2016
Price: USD 2,995.00
This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic...
颁补迟补濒辞驳:听
La Merie Publishing
March 2015
Price: USD 140.00
Alzheimer鈥檚 disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their...
iGATE
July 2017
Price: USD 1,250.00
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects discusses trends in the over-the-counter (OTC) pharmaceuticals market and the...
颁补迟补濒辞驳:听
CBR Pharma Insights
December 2015
Price: USD 2,995.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
颁补迟补濒辞驳:听
La Merie Publishing
July 2022
Price: USD 2,000.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
颁补迟补濒辞驳:听
La Merie Publishing
November 2022
Price: USD 2,500.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
颁补迟补濒辞驳:听
La Merie Publishing
June 2022
Price: USD 1,170.00
听
